相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lipoprotein-associated phospholipase A2 (Lp-PLA2): A novel and promising biomarker for cardiovascular risks assessment
Anping Cai et al.
DISEASE MARKERS (2013)
Resveratrol inhibits neointimal formation after arterial injury through an endothelial nitric oxide synthase-dependent mechanism
Danna M. Breen et al.
ATHEROSCLEROSIS (2012)
The role of perivascular adipose tissue in vascular smooth muscle cell growth
Chao-Yu Miao et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
In-Stent Neoatherosclerosis A Final Common Pathway of Late Stent Failure
Seung-Jung Park et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Decreased circulating lipoprotein-associated phospholipase A2 levels are associated with coronary plaque regression in patients with acute coronary syndrome
Tomotaka Dohi et al.
ATHEROSCLEROSIS (2011)
Inflammatory markers in coronary heart disease
Mohammad Madjid et al.
BRITISH MEDICAL BULLETIN (2011)
Forecasting the Future of Cardiovascular Disease in the United States A Policy Statement From the American Heart Association
Paul A. Heidenreich et al.
CIRCULATION (2011)
Association of lipoprotein-associated phospholipase A2 and endothelial function in the Multi-Ethnic Study of Atherosclerosis (MESA)
Parveen K. Garg et al.
VASCULAR MEDICINE (2011)
Lipoprotein associated phospholipase A2: role in atherosclerosis and utility as a biomarker for cardiovascular risk
Kenneth J. Colley et al.
EPMA JOURNAL (2011)
The Role of Lipoprotein-Associated Phospholipase A2 (Lp-PLA(2)) in Cardiovascular Disease
Ignatios Ikonomidis et al.
REVIEWS ON RECENT CLINICAL TRIALS (2011)
Lipoprotein-associated phospholipase A2 (Lp-PLA2) and risk of cardiovascular disease in older adults: Results from the Cardiovascular Health Study
Nancy Swords Jenny et al.
ATHEROSCLEROSIS (2010)
Cardiovascular Risk Prediction Basic Concepts, Current Status, and Future Directions
Donald M. Lloyd-Jones
CIRCULATION (2010)
Phospholipase A2 inhibition and atherosclerotic vascular disease: prospects for targeting secretory and lipoprotein-associated phospholipase A2 enzymes
Robert S. Rosenson
CURRENT OPINION IN LIPIDOLOGY (2010)
Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI A Meta-analysis
Jessica L. Mega et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Impact of Delay to Angioplasty in Patients With Acute Coronary Syndromes Undergoing Invasive Management Analysis From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial
Paul Sorajja et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Lipoprotein-associated phospholipase A2 as a biomarker of coronary heart disease and a therapeutic target
Chris J. Packard
CURRENT OPINION IN CARDIOLOGY (2009)
Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study
Atsushi Tanaka et al.
EUROPEAN HEART JOURNAL (2009)
Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults
Paraskevi Detopoulou et al.
LIPIDS IN HEALTH AND DISEASE (2009)
Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention
Cedric Delhaye et al.
CARDIOVASCULAR REVASCULARIZATION MEDICINE (2009)
Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines
Michael H. Davidson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Lipoprotein-associated phospholipase A2:: An independent predictor of coronary artery disease events in primary and secondary prevention
Jeffrey L. Anderson
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker
Marshall A. Corson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population
Pia R. Kamstrup et al.
CIRCULATION (2008)
Low basal levels of circulating adiponectin in patients undergoing coronary stenting predict in-stent restenosis, independently of basal levels of inflammatory markers: Lipoprotein associated phospholipase A2, and myeloperoxidase
Elena Moldoveanu et al.
CLINICAL BIOCHEMISTRY (2008)
Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development
Robert L. Wilensky et al.
NATURE MEDICINE (2008)
New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease
Sotirios Tsimikas et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase a2 activity, and 10-year cardiovascular outcomes - Prospective results from the Bruneck study
Stefan Kiechl et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death
Heidi T. May et al.
AMERICAN HEART JOURNAL (2006)
High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke
Mitchell S. V. Elkind et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
High-dose atorvastatin vs usual dose simvastatin for secondary prevention after myocardial infarction - The IDEAL study: A randomized controlled trial
TR Pedersen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Intensive lipid lowering with atorvastatin in patients with stable coronary disease
JC LaRosa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Blockade of endogenous cytokines mitigates neointimal formation in obese Zucker rats
R Takeda et al.
CIRCULATION (2005)
Intravascular adenovirus-mediated lipoprotein-associated phospholipase A2 gene transfer reduces neointima formation in balloon-denuded rabbit aorta
P Turunen et al.
ATHEROSCLEROSIS (2005)
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
CP Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting
A Segev et al.
EUROPEAN HEART JOURNAL (2004)
Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models
MB Boffa et al.
CLINICAL BIOCHEMISTRY (2004)
Plasma PAF-acetylhydrolase in patients with coronary artery disease: results of a cross-sectional analysis
S Blankenberg et al.
JOURNAL OF LIPID RESEARCH (2003)
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease.
CJ Packard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
HDL-associated PAF-AH reduces endothelial adhesiveness in apoE-/- mice
G Theilmeier et al.
FASEB JOURNAL (2000)
分享论文
